Lancet 386 (10001): 1341-52, 2015.[PUBMED Abstract] The ATAC Trialists' Group.
Arimidex, tamoxifen alone or in combination: Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.
Lancet 359 (9324): 2131-9, 2002.[PUBMED Abstract] Howell A, Cuzick J, Baum M, et al.: Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.
Lancet 365 (9453): 60-2, 2005.[PUBMED Abstract] Th√ºrlimann B, Keshaviah A, Coates AS, et al.: A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.